Vivo Capital, LLC - Q4 2023 holdings

 Value Shares↓ Weighting
DTIL ExitPrecision Biosciences Inc$0-140,255
-100.0%
-0.01%
FIXX ExitHomology Medicines, Inc.$0-370,068
-100.0%
-0.05%
AMRS ExitAmyris, Inc$0-7,750,828
-100.0%
-0.05%
RZLT ExitRezolute Inc$0-484,439
-100.0%
-0.07%
CDXS ExitCodexis, Inc$0-388,144
-100.0%
-0.08%
BCAB ExitBioAtla Inc$0-534,181
-100.0%
-0.10%
ASLN ExitAslan Pharmaceuticals Ltdads$0-568,182
-100.0%
-0.12%
IMPL ExitImpel NeuroPharma Inc$0-2,884,789
-100.0%
-0.14%
CLNN ExitClene Inc$0-2,645,338
-100.0%
-0.15%
FULC ExitFulcrum Therapeutics Inc$0-520,000
-100.0%
-0.25%
ALGS ExitAligos Therapeutics Inc$0-3,547,030
-100.0%
-0.29%
ExitUnicycive Therapeutics$0-3,470,152
-100.0%
-0.33%
IOVA ExitIovance Biotherapeutics Inc$0-655,057
-100.0%
-0.33%
ExitSera Prognostics Inc$0-1,856,011
-100.0%
-0.38%
DBVT ExitDBV Technologies SAsponsored adr$0-2,708,875
-100.0%
-0.40%
ARWR ExitArrowhead Pharmaceuticals Inc$0-137,411
-100.0%
-0.40%
BOLT ExitBolt Therapeutics Inc$0-3,871,291
-100.0%
-0.44%
ORIC ExitOric Pharmaceuticals Inc$0-777,944
-100.0%
-0.52%
TIL ExitInstil Bio Inc$0-12,486,787
-100.0%
-0.59%
ACRS ExitAclaris Therapeutics, Inc.$0-898,631
-100.0%
-0.67%
ExitAadi Bioscience Inc$0-509,572
-100.0%
-0.71%
ALLK ExitAllakos Inc$0-2,988,000
-100.0%
-0.74%
CMPX ExitCompass Therapeutics Inc$0-3,556,023
-100.0%
-0.77%
SVRA ExitSavara Inc$0-1,913,349
-100.0%
-0.79%
DCTH ExitDelcath Systems, Inc.$0-1,855,191
-100.0%
-0.82%
KALV ExitKalVista Pharmaceuticals Inc.$0-856,008
-100.0%
-0.90%
ExitApogee Therapeutics Inc$0-400,000
-100.0%
-0.93%
ExitIO Biotech Inc$0-6,173,439
-100.0%
-0.95%
DYN ExitDyne Therapeutics Inc$0-1,035,136
-100.0%
-1.02%
CRNX ExitCrinetics Pharmaceuticals Inc$0-350,000
-100.0%
-1.14%
ALPN ExitAlpine Immune Sciences Inc$0-914,913
-100.0%
-1.15%
ZLAB ExitZai Lab Ltd ADRadr$0-454,606
-100.0%
-1.21%
CMPS ExitCompass Pathway PLCsponsored ads$0-1,608,000
-100.0%
-1.30%
ExitVerastem Inc$0-1,538,461
-100.0%
-1.37%
ExitAstria Therapeutics Inc$0-1,681,199
-100.0%
-1.37%
ExitIcosavax, Inc.$0-1,704,568
-100.0%
-1.45%
ExitRayzebio Inc$0-633,576
-100.0%
-1.54%
ExitVentyx Biosciences Inc$0-422,075
-100.0%
-1.61%
ExitArcellx Inc.$0-503,565
-100.0%
-1.98%
ALXO ExitALX Oncology Holdings Inc$0-4,220,048
-100.0%
-2.22%
COGT ExitCogent Biosciences Inc$0-2,244,941
-100.0%
-2.40%
OLMA ExitOlema Pharmaceuticals Inc$0-1,873,704
-100.0%
-2.54%
VRDN ExitViridian Therapeutics Inc$0-1,678,207
-100.0%
-2.82%
GRCL ExitGracell Biotechnologies Incsponsored ads$0-10,881,144
-100.0%
-3.43%
TERN ExitTerns Pharmaceuticals Inc$0-6,657,992
-100.0%
-3.67%
GERN ExitGeron Corp$0-16,524,634
-100.0%
-3.84%
SVA ExitSinovac Biotech Ltd.$0-5,900,000
-100.0%
-4.18%
TARS ExitTarsus Pharmaceuticals Inc$0-2,262,200
-100.0%
-4.40%
AVDL ExitAvadel Pharmaceuticals PLCadr$0-4,096,428
-100.0%
-4.62%
VRNA ExitVerona Pharma PLCads$0-4,249,918
-100.0%
-7.59%
HRMY ExitHarmony Biosciences Holdings Inc$0-2,606,247
-100.0%
-9.36%
ExitSoleno Therapeutics Inc$0-3,203,093
-100.0%
-10.36%
GTH ExitGenetron Holdings Ltdads$0-8,124,174
-100.0%
-11.46%
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ACLARIS THERAPEUTICS INC29Q3 202333.5%
CODEXIS INC29Q3 20238.0%
ASCENDIS PHARMA A/S25Q3 202224.0%
KALVISTA PHARMACEUTICALS INC25Q3 20233.9%
Verona Pharma PLC ADR24Q3 20237.6%
AMYRIS INC23Q3 20238.8%
EIGER BIOPHARMACEUTICALS INC23Q1 20228.7%
Zai Lab Ltd ADR22Q3 20231.8%
Arrowhead Pharmaceuticals Inc21Q3 20236.9%
HOMOLOGY MEDICINES INC21Q3 20233.7%

View Vivo Capital, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Vivo Capital, LLC Q4 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
SINOVAC BIOTECH LTDSold outAugust 27, 201800.0%

View Vivo Capital, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-04-22
13F-HR2024-02-07
13F-HR2023-11-08
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-13
13F-HR2022-02-11

View Vivo Capital, LLC's complete filings history.

Compare quarters

Export Vivo Capital, LLC's holdings